FinscoFinsco

Fulgent Genetics (US.FLGT)

Capital Allocation Audit · Period: 2014 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.FLGT · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion154.4%↑
ROE-5.4%↓
Cash Conversion-→
D/E Ratio0.01↓
Gross Margin30.1%↓
US.FLGT (Fulgent Genetics) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion   154.4%    ↑
ROE               -5.4%    ↓
Cash Conversion       -    →
D/E Ratio          0.01    ↓
Gross Margin      30.1%    ↓
Key Metrics
US.FLGT (Fulgent Genetics) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 154.4% ↑
ROE -5.4% ↓
Cash Conversion - →
D/E Ratio 0.01 ↓
Gross Margin 30.1% ↓

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-CAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesMicron TechnologySanDiskSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies